Cutaneous manifestations of Proteus syndrome - Correlations with general clinical severity

被引:55
作者
Nguyen, D
Turner, JT
Olsen, C
Bieseckcr, LG
Darling, TN
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Dermatol, Bethesda, MD 20814 USA
[2] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA
[3] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD USA
关键词
D O I
10.1001/archderm.140.8.947
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Proteus syndrome is a rare congenital disorder with progressive asymetric overgrowth of multiple tissues. Objectives: To determine the range of cutaneous findings in Proteus syndrome and to correlate cutaneous findings with overall disease severity. Design: A prospective cohort study was performed at the National Institutes of Health, a tertiary referral center. Patients: Twenty-four consecutive children and adults with Proteus syndrome meeting recent diagnostic criteria. Interventions: Physical examination, including complete skin examination, and review of medical records. Main Outcome Measures: Frequency of skin findings correlation of skin findings with extracutaneous findings; cluster analysis of findings. Results: The 24 patients had skin abnormalities: 22 (92%) had lipomas, 21 (88%) had vascular malformations, 20 (83%) had cerebriform connective tissue nevi on the soles of the feet, 16 (67%) had epidermal nevi, 9 (38%) had partial lipohypoplasia, and 5 (21%) had patchy dermal hypoplasia. Some patients had localized alterations in skin pigmentation and hair or nail growth. Patients with a greater number of skin abnormalities tended to have a greater number of extracutaneous abnormalities. The number of abnormalities tended to increase with age up to 8 years. Conclusions: Patients with Proteus syndrome exhibit a variable but defined assortment of cutaneous findings. The correlation between numbers of cutaneous and extracutaneous abnormalities is consistent with the postulated mosaic basis for this syndrome.
引用
收藏
页码:947 / 953
页数:7
相关论文
共 28 条
[21]   Genital tract tumors in proteus syndrome: Report of a case of bilateral paraovarian endometrioid cystic tumors of borderline malignancy and review of the literature [J].
Raju, RR ;
Hart, WR ;
Magnuson, DK ;
Reid, JR ;
Rogers, DG .
MODERN PATHOLOGY, 2002, 15 (02) :172-180
[22]   PROTEUS SYNDROME [J].
SAMLASKA, CP ;
LEVIN, SW ;
JAMES, WD ;
BENSON, PM ;
WALKER, JC ;
PERLIK, PC .
ARCHIVES OF DERMATOLOGY, 1989, 125 (08) :1109-1114
[23]   Sudden death caused by pulmonary thromboembolism in Proteus syndrome [J].
Slavotinek, AM ;
Vacha, SJ ;
Peters, KF ;
Biesecker, LG .
CLINICAL GENETICS, 2000, 58 (05) :386-389
[24]   Germline mutation of the tumour suppressor PTEN in Proteus syndrome [J].
Smith, JM ;
Kirk, EPE ;
Theodosopoulos, G ;
Marshall, GM ;
Walker, J ;
Rogers, M ;
Field, M ;
Brereton, JJ ;
Marsh, DJ .
JOURNAL OF MEDICAL GENETICS, 2002, 39 (12) :937-940
[25]  
Viljoen D L, 1988, Pediatr Dermatol, V5, P14, DOI 10.1111/j.1525-1470.1988.tb00878.x
[26]   Protean PTEN: Form and function [J].
Waite, KA ;
Eng, C .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (04) :829-844
[27]   Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis [J].
Zhou, XP ;
Marsh, DJ ;
Hampel, H ;
Mulliken, JB ;
Gimm, O ;
Eng, C .
HUMAN MOLECULAR GENETICS, 2000, 9 (05) :765-768
[28]   Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes [J].
Zhou, XP ;
Hampel, H ;
Thiele, H ;
Gorlin, RJ ;
Hennekam, RCM ;
Parisi, M ;
Winter, RM ;
Eng, C .
LANCET, 2001, 358 (9277) :210-211